Barclays
TVGN icon

Barclays’s Tevogen Inc TVGN Stock Holding History

Barclays’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187 Sell
33
-216
-87% -$1.72K ﹤0.01% 5117
2026
Q1 		$1.13K Sell
249
-1,063
-81% -$13K ﹤0.01% 4896
2025
Q4 		$21.7K Buy
1,312
+171
+15% +$4.45K ﹤0.01% 4861
2025
Q3 		$44.8K Sell
1,141
-231
-17% -$11.4K ﹤0.01% 4792
2025
Q2 		$85.7K Buy
1,372
+611
+80% +$34.8K ﹤0.01% 4619
2025
Q1 		$41.1K Sell
761
-151
-17% -$9.93K ﹤0.01% 4668
2024
Q4 		$47K Buy
912
+257
+39% +$16.7K ﹤0.01% 4777
2024
Q3 		$12.1K Buy
655
+505
+337% +$14.8K ﹤0.01% 4955
2024
Q2 		$5.44K Buy
+150
New +$9.77K ﹤0.01% 4573
2023
Q1 		– Sell
-714
Closed -$369K – 5404
2022
Q4 		$369K Sell
714
-3,000
-81% -$1.54M ﹤0.01% 3498
2022
Q3 		$1.88M Hold
3,714
– – ﹤0.01% 1792
2022
Q2 		$1.86M Hold
3,714
– – ﹤0.01% 1902
2022
Q1 		$1.85M Buy
+3,714
New +$1.85M ﹤0.01% 1922

Other funds holding TVGN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Barclays's TVGN Position: Q2 2026 in Review

Barclays reduced its Tevogen Inc (TVGN) stake by 87% in Q2 2026, selling an estimated $1.72K and leaving 33 shares worth $187. The position accounts for ﹤0.01% of the portfolio, ranked #5117.

Barclays first reported a position in TVGN in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.88M in Q3 2022. 30 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

  • Barclays held 33 shares of Tevogen Inc worth $187 as of Q2 2026.
  • Barclays sold 216 Tevogen Inc shares in Q2 2026, an estimated $1.72K.
  • Tevogen Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5117 holding.
  • Barclays first reported a position in Tevogen Inc in Q1 2022 and has held it in 13 quarters since.
  • Barclays's Tevogen Inc position peaked at $1.88M in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.